Contemporary management of cardiovascular implantable electronic device infections.
Cardiovascular implantable electronic device (CIED) implantation rate has substantially risen in the foregoing decades. Unfortunately, this upsurge in CIED implantation rate has been accompanied by a disproportionate rise in the rate of CIED infections. Device infection is a major complication of CIED implantation, necessitating removal of an infected device followed by systemic antimicrobial therapy and reimplantation of a new system. In this article, we review the current epidemiology, risk factors, diagnostic strategy and contemporary management of CIED infection. In addition, we address the vexing question of how to best manage patients with Staphylococcus aureus bacteremia, in the setting of an implanted device, but no overt clinical signs of CIED infection. Lastly, we discuss the preventive strategies to minimize risk of CIED infection.
Sohail
Muhammad R
MR
Division of Infectious Diseases, 200 First Street SW, Rochester, MN 55905, USA. sohail.muhammad@mayo.edu
Sultan
Omer W
OW
Raza
Sania S
SS
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000188:drug therapy*; D017147:Defibrillators, Implantable / Q000382:microbiology*; D020878:Device Removal; D006801:Humans; D010138:Pacemaker, Artificial / Q000382:microbiology*; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents